The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer

Gynecologic Oncology

Volumn 131, Issue 2, 2013, Pages 451-459

  Dai, Furong ^a   Zhang, Yi ^a   Zhu, Xin ^a   Shan, Nianchun ^a   Chen, Yuxiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Animal model; Aptamer; Cancer stem cell; miRNA; Ovarian cancer; PTEN

Indexed keywords

APTAMER; MICRORNA 29B; MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE 4; MUCIN 1; PACLITAXEL; SOMATOMEDIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER STEM CELL; CHIMERA; DOWN REGULATION; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; METHYLATION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; XENOGRAFT;

ANIMAL MODEL; APTAMER; CANCER STEM CELL; MIRNA; OVARIAN CANCER; PTEN;

ANIMALS; APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MUCIN-1; OVARIAN NEOPLASMS; PACLITAXEL; PTEN PHOSPHOHYDROLASE; RANDOM ALLOCATION; RECOMBINANT FUSION PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84886091090     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.07.112     Document Type: Article

References (36)

1. D. Van Simaeys, D. López-Colón, K. Sefah, R. Sutphen, E. Jimenez, and W. Tan Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX PLoS One 5 2010 e13770
2. P. Hartge Designing early detection programs for ovarian cancer J Natl Cancer Inst 102 2010 3 4
3. L.J. Willmott, and J.P. Fruehauf Targeted therapy in ovarian cancer J Oncol 2010 2010 740472
4. L.M. Hess, N. Rong, P.O. Monahan, P. Gupta, C. Thomaskutty, and D. Matei Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysis Cancer 116 2010 5251 5260
5. G. Mor, G. Yin, I. Chefetz, Y. Yang, and A. Alvero Ovarian cancer stem cells and inflammation Cancer Biol Ther 11 2011 708 713
6. F.J. Collinson, J. Seligmann, and T.J. Perren Ovarian cancer: advances in first-line treatment strategies with a particular focus on anti-angiogenic agents Curr Oncol Rep Sep. 5 2012 [Epub ahead of print]
7. D. Teoh, and A.A. Secord Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer Int J Gynecol Cancer 22 2012 348 359
8. F. Dai, Y. Zhang, X. Zhu, N. Shan, and Y. Chen Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation Target Oncol 7 2012 217 225
9. E. Bernstein, A.A. Caudy, S.M. Hammond, and G.J. Hannon Role for a bidentate ribonuclease in the initiation step of RNA interference Nature 409 2001 363 366
10. I.J. Macrae, K. Zhou, F. Li, A. Repic, A.N. Brooks, and W.Z. Cande Structural basis for double-stranded RNA processing by Dicer Science 311 2006 195 198
11. R. Garzon, S. Liu, M. Fabbri, Z. Liu, C.E. Heaphy, and E. Callegari MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 Blood 113 2009 6411 6418
12. N. Sato, H. Tsunoda, M. Nishida, Y. Morishita, Y. Takimoto, and T. Kubo Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary Cancer Res 60 2000 7052 7056
13. A. Dai, Y. Huang, and W. Sadee Growth factor signaling and resistance to cancer chemotherapy Curr Top Med Chem 4 2004 1347 1356
14. T.H. Yen, and N.A. Wright The gastrointestinal tract stem cell niche Stem Cell Rev 2 2006 203 212
15. B. Dave, and J. Chang Treatment resistance in stem cells and breast cancer J Mammary Gland Biol Neoplasia 14 2009 79 82
16. H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, and M. Bronner-Fraser Cancerous stem cells can arise from pediatric brain tumors Proc Natl Acad Sci U S A 100 2003 15178 15183
17. J. Douville, R. Beaulieu, and D. Balicki ALDH1 as a functional marker of cancer stem and progenitor cells Stem Cells Dev 18 2009 17 25
18. H. Riveros-Rosas, A. Julian-Sanchez, and E. Pina Enzymology of ethanol and acetaldehyde metabolism in mammals Arch Med Res 28 1997 453 471
19. N.E. Sladek, R. Kollander, L. Sreerama, and D.T. Kiang Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens Cancer Chemother Pharmacol 49 2002 309 321
20. M. Han, M. Liu, Y. Wang, X. Chen, J. Xu, and Y. Sun Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN PLoS One 7 2012 e39520
21. K.F. Tam, V.W. Liu, S.S. Liu, P.C. Tsang, A.N. Cheung, and A.M. Yip Methylation profile in benign, borderline and malignant ovarian tumors J Cancer Res Clin Oncol 133 2007 331 341
22. C. Lu, M.M. Shahzad, M. Moreno-Smith, Y.G. Lin, N.B. Jennings, and J.K. Allen Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models Cancer Biol Ther 9 2010 176 182
23. C.L. Esposito, D. Passaro, I. Longobardo, G. Condorelli, P. Marotta, and A. Affuso A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death PLoS One 6 2011 e24071
24. X. Zhang, T. Kon, H. Wang, F. Li, Q. Huang, and Z.N. Rabbani Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha Cancer Res 64 2004 8139 8142
25. M. Karsy, L. Albert, M.E. Tobias, R. Murali, and M. Jhanwar-Uniyal All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner Anticancer Res 30 2010 4915 4920
26. A.S. Bodzin, Z. Wei, R. Hurtt, T. Gu, and C. Doria Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation J Cell Physiol 227 2012 2947 2952
27. L. Kelland The resurgence of platinum-based cancer chemotherapy Nat Rev Cancer 7 2007 573 584
28. J. Li, Y. Zhang, J. Zhao, F. Kong, and Y. Chen Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells Mol Cell Biochem 357 2011 31 38
29. J.T. De Ligio, A. Velkova, D.A. Zorio, and A.N. Monteiro Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy? Anticancer Agents Med Chem 9 2009 543 549
30. C. Blanco-Aparicio, O. Renner, J.F. Leal, and A. Carnero PTEN, more than the AKT pathway Carcinogenesis 28 2007 1379 1386
31. T.F. Franke PI3K/Akt: getting it right matters Oncogene 27 2008 6473 6488
32. L.S. Steelman, F.E. Bertrand, and J.A. McCubrey The complexity of PTEN: mutation, marker and potential target for therapeutic intervention Expert Opin Ther Targets 8 2004 537 550
33. E. Sasabe, Y. Tatemoto, D. Li, T. Yamamoto, and T. Osaki Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells Cancer Sci 96 2005 394 402
34. D. Hambardzumyan, O.J. Becher, M.K. Rosenblum, P.P. Pandolfi, K. Manova-Todorova, and E.C. Holland PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo Genes Dev 22 2008 436 448
35. N. Sato, H. Tsunoda, M. Nishida, Y. Morishita, Y. Takimoto, and T. Kubo Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary Cancer Res 60 2000 7052 7056
36. C.M. Ho, M.C. Lin, S.H. Huang, C.J. Huang, H.C. Lai, and T.Y. Chien PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas Gynecol Oncol 112 2009 307 313